Jobs

GlaxoSmithKline has acquired rights to several inhaled drug candidates manufactured using Liquidia Technologies’ PRINT (Particle Replication In Non-Wetting Templates) platform. The PRINT nanofabrication technology produces particles with narrow size distribution and any desired shape. According… Read more . . .

Particle design and dry powder inhalation specialist Hovione has announced that sales for the fiscal year that ended in March, 2012 increased to $180 million,a 24% increase over the previous year. In addition to inhalation… Read more . . .

MicroDose Therapeutx and Moerae Matrix have agreed to collaborate on development of a dry powder inhaler, using MicroDose DPI technology to deliver Moerae’s MMI-0100 MK2 inhibitor for the treatment of idiopathic pulmonary fibrosis (IPF). There… Read more . . .

According to Bloomberg News, Merck plans to appeal a ruling by Judge Peter Sheridan of the US District Court for the District of New Jersey that Merck failed to prove its allegation that Apotex infringed… Read more . . .

Rigel Pharmaceuticals has granted AstraZeneca an exclusive worldwide license for development and commercialization of its R256 inhaled JAK inhibitor for the treatment for moderate to severe asthma. The deal includes an upfront payment of $1… Read more . . .

A new report from Transparency Market Research titled “Asthma and COPD Drug Market – Global Industry Analysis, Market Size, Share, Trends, Growth and Forecasts, 2010 – 2017” predicts an increase in the asthma and COPD… Read more . . .

Impel NeuroPharma says that a study has shown that its Pressurized Olfactory Device (POD) was preferred 2 to 1 by testers compared to conventional nasal sprays. POD delivers aerosolized drug, both liquid and powder formulations,… Read more . . .